BE621147A - - Google Patents

Info

Publication number
BE621147A
BE621147A BE621147DA BE621147A BE 621147 A BE621147 A BE 621147A BE 621147D A BE621147D A BE 621147DA BE 621147 A BE621147 A BE 621147A
Authority
BE
Belgium
Prior art keywords
aggregates
cellulose
sep
crystallites
polymerization
Prior art date
Application number
Other languages
English (en)
French (fr)
Publication of BE621147A publication Critical patent/BE621147A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
BE621147D BE621147A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE621147T

Publications (1)

Publication Number Publication Date
BE621147A true BE621147A (de)

Family

ID=3875687

Family Applications (1)

Application Number Title Priority Date Filing Date
BE621147D BE621147A (de)

Country Status (2)

Country Link
BE (1) BE621147A (de)
FR (1) FR2695M (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2007475A1 (de) * 1968-04-18 1970-01-09 Garland Richard Brown
EP0001247A1 (de) * 1977-09-14 1979-04-04 Kanebo, Ltd. Nifedipine enthaltendes Arzneipräparat und Verfahren zu seiner Herstellung.
EP0237506A1 (de) * 1986-02-14 1987-09-16 Lejus Medical Aktiebolag Pharmazeutische Zusammensetzung

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU508480B2 (en) * 1977-04-13 1980-03-20 Asahi Kasei Kogyo Kabushiki Kaisha Microcrystalline cellulose excipient and pharmaceutical composition containing thesame

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2007475A1 (de) * 1968-04-18 1970-01-09 Garland Richard Brown
EP0001247A1 (de) * 1977-09-14 1979-04-04 Kanebo, Ltd. Nifedipine enthaltendes Arzneipräparat und Verfahren zu seiner Herstellung.
EP0237506A1 (de) * 1986-02-14 1987-09-16 Lejus Medical Aktiebolag Pharmazeutische Zusammensetzung

Also Published As

Publication number Publication date
FR2695M (fr) 1964-08-03

Similar Documents

Publication Publication Date Title
US3146168A (en) Manufacture of pharmaceutical preparations containing cellulose crystallite aggregates
EP1873196B1 (de) Poröses celluloseaggregat und formzusammensetzung damit
DE69231499T2 (de) Zusammensetzung auf der basis von mikrokristalliner zellulose für die herstellung von kugelförmigen teilchen
CA2261092A1 (fr) Additivation de nanofibrilles de cellulose avec de la cellulose carboxylee a bas degre de substitution
CA2755992C (fr) Coagglomerats de mannitol et d'amidon granulaire comprimables et a ecoulement libre
JPS6090234A (ja) 固形物コーティング用フイルム形成性組成物
FR2484834A1 (fr) Composition pharmaceutique contenant des sels d'aluminium de l'ibuprofene
FR2671353A1 (fr) Colles pour papiers muraux a base de matieres polymeres adhesives hydrosolubles.
LU85850A1 (fr) Compositions pour les soins des voies respiratoires
NAGPAL et al. Extraction of gum from Abelmoschus esculentus: Physicochemical peculiarity and antioxidant prepatent
WO2004043166A1 (fr) Utilisation de maltodextrines branchees comme liants de granulation
CA2814184C (fr) Poudre de polysaccharide et de polyol, comprimable et de haute viscosite
CA2287485A1 (fr) Nouveau procede d'obtention de microspheres et les produits ainsi realises
BE621147A (de)
EP1658329A1 (de) Pulver- oder kornförmige zusammensetzung auf basis von leguminosenstärken und verwendung davon bei nichtlebensmittel- und nichtpharma-anwendungen
FR2529784A1 (fr) Medicament a liberation retardee contenant du 1-(p-(isopropylthio)-phenyl)-2-octylamino-1-propanol
JP5903250B2 (ja) 徐放性組成物
FR2460666A1 (fr) Procede pour preparer, a l'aide de polysaccharides du soja, des compositions pharmaceutiques a desagregation facile
Momoh et al. Biochemical, rheological and hydrophile-lipophile balance (HLB) evaluation of Archachatina marginata (snail) mucin extract for possible nutraceutical and nano biopharmaceutical applications
WO2020012140A1 (fr) Excipient sous forme solide comprenant un ensemble de fibres alimentaires végétales non modifiées chimiquement
EP1582222B1 (de) Pulverförmige oberflächenaktive Stoffe zur Verwendung in Tabletten oder Kapseln, ihre Herstellungsverfahren und diese enthaltende Zubereitungen
BE838506R (fr) Comprimes contenant une combinaison d'une 2,4-diaminopyrimidine avec un sulfonamide
Nwachukwu et al. Evaluation of Modified Pennisetum glaucum Starch as a Suspending Agent in Metronidazole Benzoate Suspension:(TJPS-2020-0241. R1)
Kadoli et al. Study of Binding Efficiency of Tapioca Starch using Iornoxicam as a Model Drug
EP1409002B9 (de) Sphäroide aus adsorbaten von pflanzenextrakten und herstellungsverfahren